MSI2 and chronic myelogenous leukemia, BCR-ABL1 positive: Research has found that BCAT1 is abnormally activated in chronic myeloid leukemia (CML) in both humans and mice, promoting BCAAs production via the MSI2-BCAT1 axis, thereby driving the development of myeloid leukemia (Hattori et al., 2017).